DSJ Global are proud to be supporting this global life sciences player, driving forward ground-breaking developments in Cell and Gene therapies. With ever-increasing demands in the industry, this Business Unit has huge growth plans (including the opening and ramp-up of this new site), whilst continuing to set the industry gold-standard. Taking on the growth responsibilities of this site, as well as the Swiss entity, this position will play a vital role in the success of the BU.
Role Responsibilities:
- Lead the Operations for this high-growth Business unit (including the ramp-up of a brand-new site) across Switzerland and Germany
- Responsible for the wider strategic direction of the business unit, including P+L Responsibilities
- Manage the operational systems, including the creation and development of brand new systems/processes for the opening facility
- Lead the growth of the European team; training and developing existing employees, as well recruiting new hires for the high-growth strategy
- Implement continuous improvement and change management initiatives, consistently driving performance culture
Skills/Experience Required:
- Experienced working within a GMP environment
- Experienced with Cold-chain logistics (Cryo/LN2 transportation & warehousing)
- Ability to lead and motivate teams, fostering a strong team culture
- Understanding of ISO 9001
- Holistic understanding of the End-to-End Supply Chain, including production and operations #
- Ability to understand the macro business-needs of the BU to develop future strategy
What the role offers you:
- Greenfield mission, leading the development of a brand new site, within a rapidly growing Business Unit
- Contribute to highly beneficial research and development within the Life Sciences industry, which will make a global impact
- High-level responsibility, governing strategy and P+L responsibility for the Business Unit
- Opportunity to grow and develop a team from scratch
- Great company benefits
We look forward to your application. Please contact Chris Williams for more details.